Evaluation of Long-Term Follow-Up in Ecchordosis Physaliphora versus Chordoma.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 28 02 2023
accepted: 05 03 2023
medline: 5 6 2023
pubmed: 11 3 2023
entrez: 10 3 2023
Statut: ppublish

Résumé

Ecchordosis physaliphora (EP) is a non-neoplastic notochord remnant with limited literature. We present a review on surgically resected clival EP to evaluate if available follow-up is adequate to distinguish EP from chordomas. A systematic literature review was completed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Case reports or series of adults with histopathologic and radiographic findings of surgically resected EP were included. Articles including pediatric patients, systematic reviews, chordomas, and without microscopic or radiographic confirmation, or the surgical approach, were excluded. Corresponding authors were contacted twice to further evaluate outcomes. Eighteen articles were included (n = 25 patients; mean age 47.5 years ± 12.6 [standard deviation] months). All patients had symptomatic, surgically resected EP, with cerebrospinal fluid leak or rhinorrhea the most common symptom (48%). All but 3 had gross total resection, with endoscopic endonasal transsphenoidal transclival the most common approach (80%). All but 3 reported immunohistochemistry findings, with physaliphorous cells the most common. All but 5 patients had definitive follow-up (80%), with average of 19.5 ± 17.2 months. One corresponding author reported longer-term follow-up for 1 patient (57 months). No recurrence or malignant transformation was reported. Mean time to clival chordoma recurrence (53.9 ± 26.8 months) was also evaluated in a review of 8 studies. Mean follow-up for resected EP was almost 3 times shorter than mean time to recurrence of chordomas. Available literature is likely inadequate to confirm the suspected benign nature of EP especially in reference to chordoma, precluding treatment and follow-up recommendations.

Identifiants

pubmed: 36898627
pii: S1878-8750(23)00310-8
doi: 10.1016/j.wneu.2023.03.016
pii:
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-168

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Caren M Stuebe (CM)

Department of Neurosurgery, Texas A&M School of Medicine, Bryan, Texas, USA.

Rima S Rindler (RS)

Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.

Nadia Laack (N)

Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.

Carrie M Carr (CM)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

Garret Choby (G)

Department of Otolaryngology (ENT)/Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.

Carrie Y Inwards (CY)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Jamie J Van Gompel (JJ)

Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: Vangompel.jamie@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH